Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study


Koca S., Besiroglu M., Ozcelik M., Karaca M., BİLİCİ M., Hacioglu B., ...Daha Fazla

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, cilt.27, sa.3, ss.541-546, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1177/1078155220924075
  • Dergi Adı: JOURNAL OF ONCOLOGY PHARMACY PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
  • Sayfa Sayıları: ss.541-546
  • Anahtar Kelimeler: Pazopanib, soft tissue sarcoma, targeted therapy, RANDOMIZED PHASE-II, SPANISH GROUP, GEMCITABINE, RISK
  • İnönü Üniversitesi Adresli: Evet

Özet

Purpose